These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 27073698)

  • 21. Drug Repurposing in Neurological Disorders: Implications for Neurotherapy in Traumatic Brain Injury.
    Shakkour Z; Habashy KJ; Berro M; Takkoush S; Abdelhady S; Koleilat N; Eid AH; Zibara K; Obeid M; Shear D; Mondello S; Wang KK; Kobeissy F
    Neuroscientist; 2021 Dec; 27(6):620-649. PubMed ID: 33089741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Repurposing of drugs approved for cardiovascular diseases: Opportunity or mirage?
    Gelosa P; Castiglioni L; Camera M; Sironi L
    Biochem Pharmacol; 2020 Jul; 177():113895. PubMed ID: 32145263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening-based approaches.
    Ahmed F; Kang IS; Kim KH; Asif A; Rahim CSA; Samantasinghar A; Memon FH; Choi KH
    J Med Virol; 2023 Apr; 95(4):e28693. PubMed ID: 36946499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein sequence analysis in the context of drug repurposing.
    García Sánchez N; Ugarte Carro E; Prieto-Santamaría L; Rodríguez-González A
    BMC Med Inform Decis Mak; 2024 May; 24(1):122. PubMed ID: 38741115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IUPHAR review - Data-driven computational drug repurposing approaches for opioid use disorder.
    Gao Z; Ding P; Xu R
    Pharmacol Res; 2024 Jan; 199():106960. PubMed ID: 37832859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review on drug repurposing applicable to obesity.
    Chen F; Jing K; Zhang Z; Liu X
    Obes Rev; 2024 Oct; ():e13848. PubMed ID: 39384341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Turning liabilities into opportunities: Off-target based drug repurposing in cancer.
    Palve V; Liao Y; Remsing Rix LL; Rix U
    Semin Cancer Biol; 2021 Jan; 68():209-229. PubMed ID: 32044472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of Small Molecule PARKIN Activator from Antipsychotic/Anti-neuropsychiatric Drugs as Therapeutics for PD: an In Silico Repurposing Approach.
    Ibrahim A; Ipinloju N; Atasie NH; Babalola RM; Muhammad SA; Oyeneyin OE
    Appl Biochem Biotechnol; 2023 Oct; 195(10):5980-6002. PubMed ID: 36735144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Emerging strategies on in silico drug development against COVID-19: challenges and opportunities.
    Yadav M; Dhagat S; Eswari JS
    Eur J Pharm Sci; 2020 Dec; 155():105522. PubMed ID: 32827661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarker-guided repurposing of chemotherapeutic drugs for cancer therapy: a novel strategy in drug development.
    Stenvang J; Kümler I; Nygård SB; Smith DH; Nielsen D; Brünner N; Moreira JM
    Front Oncol; 2013 Dec; 3():313. PubMed ID: 24400218
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
    Moreira-Silva F; Camilo V; Gaspar V; Mano JF; Henrique R; Jerónimo C
    Pharmaceutics; 2020 Apr; 12(5):. PubMed ID: 32365701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unlocking the potential of signature-based drug repurposing for anticancer drug discovery.
    Biswal S; Mallick B
    Arch Biochem Biophys; 2024 Nov; 761():110150. PubMed ID: 39265695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities.
    Porta EOJ; Kalesh K; Steel PG
    Front Pharmacol; 2023; 14():1233253. PubMed ID: 37576826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overcoming cancer therapeutic bottleneck by drug repurposing.
    Zhang Z; Zhou L; Xie N; Nice EC; Zhang T; Cui Y; Huang C
    Signal Transduct Target Ther; 2020 Jul; 5(1):113. PubMed ID: 32616710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Revitalizing Cancer Treatment: Exploring the Role of Drug Repurposing.
    Malla R; Viswanathan S; Makena S; Kapoor S; Verma D; Raju AA; Dunna M; Muniraj N
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A review of computational drug repurposing.
    Park K
    Transl Clin Pharmacol; 2019 Jun; 27(2):59-63. PubMed ID: 32055582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug repurposing - A search for novel therapy for the treatment of diabetic neuropathy.
    Paul A; Kumar M; Das P; Guha N; Rudrapal M; Zaman MK
    Biomed Pharmacother; 2022 Dec; 156():113846. PubMed ID: 36228378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A High-Throughput Screening Approach To Repurpose FDA-Approved Drugs for Bactericidal Applications against Staphylococcus aureus Small-Colony Variants.
    Trombetta RP; Dunman PM; Schwarz EM; Kates SL; Awad HA
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30381352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational-based drug repurposing methods in COVID-19.
    Masoudi-Sobhanzadeh Y
    Bioimpacts; 2020; 10(3):205-206. PubMed ID: 32793443
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.